It is not a doc in the box

The Burden of Proving Licensure Defenses in No-Fault Cases

In New York no-fault insurance litigation, insurance companies frequently assert that healthcare providers lacked proper licensing when they rendered services, thereby making the claims uncompensable. These “licensure defenses” require insurers to prove that the provider was not authorized to operate at the time services were provided. However, proving the negative—that a license did not exist—presents evidentiary challenges that insurers must navigate carefully.

The recent Appellate Term decision in Quality Health Supply Corp. v Progressive Insurance Co. illustrates how courts scrutinize the evidence insurers present to establish licensure defenses. This case demonstrates that technical proof requirements cannot be satisfied through imprecise documentation, even when insurers believe they have identified the right entity. The decision also highlights the distinction between different types of regulatory violations and their impact on claim eligibility.

Case Background

Quality Health Supply Corp., a durable medical equipment (DME) supplier, sought payment from Progressive Insurance Company for medical products provided to an insured patient. Progressive defended the action by asserting that Quality Health lacked the necessary New York City Department of Consumer Affairs license during the relevant time period—January 2010 through June 2016.

At trial, Progressive presented testimony from a senior litigation representative and certified FOIL (Freedom of Information Law) documents obtained from the Department of Consumer Affairs. These documents purported to show that no license existed for the plaintiff during the disputed timeframe. However, a critical discrepancy emerged: the FOIL evidence showed that an entity named “Quality Heath Supply Corp. Inc.” (note the misspelling of “Health” as “Heath” and the inclusion of “Inc.”) lacked licensing, but the plaintiff’s actual corporate name was “Quality Health Supply Corp.” without the “Inc.” designation and with the correct spelling.

Quality Health Supply Corp. v Progressive Ins. Co., 2021 NY Slip Op 51028(U)(App. Term 2d Dept. 2021)

“Upon a review of the record, we find that the testimony of defendant’s senior litigation representative, as well as the certified FOIL documents entered into evidence at trial, were insufficient to establish that plaintiff did not have a Department of Consumer Affairs license for the time period of January 2010 to June 2016 (cf. Bath Med. Supply, Inc. v Allstate Indem. Co., 27 Misc 3d 92 ). The FOIL evidence solely established that a company named “Quality Heath Supply Corp. Inc.” was not licensed during this time period and no evidence was provided that plaintiff “Quality Health Supply Corp.” is the same entity as “Quality Health Supply Corp. Inc.” As there was no other evidence to establish that plaintiff was not properly licensed at the time it sold the durable medical products to its assignor, plaintiff should have been awarded a judgment in its favor.”

Let us assume of for the sake of argument that Progressive got this right. The Mallela case is clear that technical violations will not satisfy an insurance carrier’s burden to prove a non licensure defense. The Appellate Division was clear that PHL violations were not sufficient to withhold medical benefits. Mallela is limited to the “doc in a box” defense. Beyond that, a claim for fraud or the monthly Rico’s that GEICO files is the way around this.

Legal Significance

This decision reinforces a fundamental principle of civil litigation: the party asserting a defense bears the burden of proving every element of that defense with sufficient specificity. In licensure cases, insurers cannot rely on “close enough” evidence showing that a similarly named entity lacked licensing. The Appellate Term’s requirement of proof that the plaintiff and the unlicensed entity are “the same entity” reflects courts’ unwillingness to allow speculation or assumption to substitute for actual proof.

The decision also illustrates the interplay between different types of regulatory defenses in no-fault litigation. Jason’s analysis references the “Mallela defense,” which relates to the Court of Appeals decision in Presbyterian Hospital v Maryland Casualty Co., known colloquially as Mallela. That case established that certain technical regulatory violations—particularly Public Health Law violations that don’t go to the fundamental authorization to operate—cannot defeat otherwise valid no-fault claims.

Jason’s observation that “Mallela is limited to the ‘doc in a box’ defense” refers to situations where providers lack fundamental authorization to practice medicine or provide healthcare services. The Quality Health Supply case differs because it involves a DME supplier’s licensing rather than a healthcare provider’s medical practice authorization. However, the evidentiary burden remains the same: insurers must prove with specificity that the entity seeking payment lacked required licensing.

Jason’s concluding point about fraud claims and RICO actions reflects an important strategic consideration for insurers. When licensure defenses fail due to evidentiary insufficiency, insurers may pursue alternative theories such as fraud in the inducement or civil RICO claims. These approaches, while more complex and resource-intensive, allow insurers to challenge providers based on broader patterns of misconduct rather than narrow technical licensing issues.

Practical Implications

For insurance companies, this case provides crucial guidance on assembling licensure defense evidence. FOIL requests and government records remain valuable tools, but insurers must ensure that the records precisely match the defendant’s legal name and corporate structure. Before trial, defense counsel should obtain: (1) certified documents showing the exact corporate name of the plaintiff from the Secretary of State; (2) FOIL responses that use that precise corporate name; and (3) if necessary, testimony from government licensing officials who can confirm that variations in naming (such as “Inc.” vs. no “Inc.”) refer to the same or different entities.

For healthcare providers and DME suppliers, this decision demonstrates that technical name discrepancies can defeat licensure defenses. Providers should maintain clear corporate records showing their exact legal names and ensure consistency across all licensing applications and business documents. When insurers assert licensure defenses, providers should carefully review the evidence for any naming discrepancies or other technical defects that might undermine the insurer’s proof.

Related Articles

• Understanding CPLR 3212(g) paradigm for summary judgment evidence
• Critical timing rules for summary judgment motions under CPLR 3212(a)
• When partial compliance with no-fault verification requirements falls short
• Establishing reasonable excuse despite jurisdictional challenges
• New York No-Fault Insurance Law